中国胆固醇教育计划调脂治疗降低心血管事件专家建议(2019)  

China cholesterol education program(CCEP)expert advice for the management of dyslipidaemias to reduce cardiovascular risk(2019)

作　　者：无 史旭波[5] 胡大一[6] 赵水平[7] 无;Hu Dayi(China Cholesterol Education Program(CCEP)Working Committee;Atherosclerosis Thrombosis Prevention and Control Subcommittee of Chinese International Exchange and Promotion Association for Medical and Healthcare;Cardiovascular Disease Subcommittee of China Association of Gerontology and Geriatrics;Atherosclerosis Professional Committee of Chinese College of Cardiovascular Physicians;不详)

机构地区：[1]中国胆固醇教育计划(CCEP)工作委员会 [2]中国医疗保健国际交流促进会动脉粥样硬化血栓疾病防治分会 [3]中国老年学和老年医学学会心血管病分会 [4]中国医师协会心血管内科医师分会动脉粥样硬化专业委员会 [5]首都医科大学附属北京同仁医院心血管中心 [6]北京大学人民医院心内科 [7]中南大学湘雅二医院心血管内科

出　　处：《中华内科杂志》2020年第1期18-22,共5页Chinese Journal of Internal Medicine

摘　　要：我国居民血脂异常的流行趋势日趋严重,对动脉粥样硬化性心血管疾病的防治形成严峻挑战。近年来一系列新的研究结果陆续发表,为血脂异常管理策略提供了很多新信息,为使这些新的研究成果更加合理有效地应用于临床实践,进一步推动我国血脂异常防治工作,中国胆固醇教育计划(CCEP)工作委员会特组织专家对《2014年中国胆固醇教育计划血脂异常防治专家建议》进行修订,针对心血管病危险分层提出新的划分标准并更新了调脂治疗目标值。The prevalence of dyslipidemia in Chinese adult is increasing dramatically,which poses a severe challenge to the prevention and treatment of atherosclerotic cardiovascular diseases.In recent years,a series of new research results have been published,providing a lot of new information for the management strategy of dyslipidemia.In order to apply these new research results to clinical practice for the further prevention and treatment of dyslipidemia more reasonably and effectively,the China Cholesterol Education Program(CCEP)Working Committee organized joint expert meeting and revised the"Expert Advice on Prevention and Treatment of Dyslipidemia in China Cholesterol Education Program 2014",in which a new classification standard for cardiovascular risk stratification has been proposed,and the target value of lipid-lowering therapy has been updated.

关 键 词：调脂治疗 动脉粥样硬化性心血管疾病 心血管事件 危险分层 心血管病 血脂异常防治 临床实践 流行趋势 

分 类 号：R54[医药卫生—心血管疾病] R589[医药卫生—内科学]